Laboratorio de Investigaciones del Sistema Inmune (LISIN) - FCE - Universidad Nacional de La Plata, La Plata, Buenos Aires, Argentina.
Clin Exp Immunol. 2010 Oct;162(1):138-45. doi: 10.1111/j.1365-2249.2010.04192.x.
During intestinal transplant (ITx) operation, intestinal lymphatics are not reconstituted. Consequently, trafficking immune cells drain freely into the abdominal cavity. Our aim was to evaluate whether leucocytes migrating from a transplanted intestine could be recovered from the abdominal draining fluid collected by a peritoneal drainage system in the early post-ITx period, and to determine potential applications of the assessment of draining cellular populations. The cell composition of the abdominal draining fluid was analysed during the first 11 post-ITx days. Using flow cytometry, immune cells from blood and draining fluid samples obtained the same day showed an almost complete lymphopenia in peripheral blood, whereas CD3(+) CD4(+) CD8(-) , CD3(+) CD4(-) CD8(+) and human leucocyte antigen D-related (HLA-DR)(+) CD19(+) lymphocytes were the main populations in the draining fluid. Non-complicated recipients evolved from a mixed leucocyte pattern including granulocytes, monocytes and lymphocytes to an exclusively lymphocytic pattern along the first post-ITx week. At days 1-2 post-Itx, analysis by short tandem repeats fingerprinting of CD3(+) CD8(+) sorted T cells from draining fluid indicated that 50% of cells were from graft origin, whereas by day 11 post-ITx this proportion decreased to fewer than 1%. Our results show for the first time that the abdominal drainage fluid contains mainly immune cells trafficking from the implanted intestine, providing the opportunity to sample lymphocytes draining from the grafted organ along the post-ITx period. Therefore, this analysis may provide information useful for understanding ITx immunobiology and eventually could also be of interest for clinical management.
在肠移植(ITx)手术中,肠淋巴管不会重建。因此,免疫细胞会自由地流入腹腔。我们的目的是评估在 ITx 后早期,从腹腔引流系统收集的腹部引流液中是否可以回收从移植肠迁移的白细胞,并确定评估引流细胞群的潜在应用。在 ITx 后 11 天内分析了腹部引流液的细胞组成。使用流式细胞术,同一天从血液和引流液样本中获得的免疫细胞在外周血中表现出几乎完全的淋巴细胞减少,而 CD3(+) CD4(+) CD8(-)、CD3(+) CD4(-) CD8(+)和人类白细胞抗原 D 相关(HLA-DR)(+) CD19(+)淋巴细胞是引流液中的主要群体。无并发症的受者从包括粒细胞、单核细胞和淋巴细胞在内的混合白细胞模式演变为沿 ITx 后第一周的纯淋巴细胞模式。在 ITx 后 1-2 天,对引流液中 CD3(+) CD8(+)分选 T 细胞的短串联重复指纹分析表明,50%的细胞来自移植物,而在 ITx 后 11 天,这一比例下降到不到 1%。我们的结果首次表明,腹腔引流液主要含有从植入肠迁移的免疫细胞,为沿 ITx 后期间从移植器官引流的淋巴细胞取样提供了机会。因此,这种分析可能提供有助于理解 ITx 免疫生物学的信息,最终也可能对临床管理感兴趣。